AI assistant
PALISADE BIO, INC. — Director's Dealing 2019
Oct 11, 2019
35274_dirs_2019-10-11_a3d29266-6847-4c26-a031-8b1815cbf86c.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Neuralstem, Inc. (CUR)
CIK: 0001357459
Period of Report: 2019-07-19
Reporting Person: GRAY MARY ANN (Director)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 7355 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Common Stock Purchase Option | $5.90 | 2029-07-01 | Common Stock (4954) | Direct | |
| Restricted Stock Units | $ | Common Stock (4904) | Direct |
Footnotes
F1: The shares represented are restricted stock grants pursuant to 45% of compensatory Annual Grant for director services equal to $100,000. The shares vest quarterly on 9/30/19, 12/31/19, 3/31/,20 and 6/30/20.
F2: Represents 25% of compensatory Annual Grant for director services equal to $100,000. The options vest quarterly on 9/30/19, 12/31/19, 3/31/20, and 6/30/20.
F3: Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock.
F4: Represents 30% of compensatory Annual Grant for director services of $100,000. The RSU's vest quarterly on 9/30/19, 12/31/19, 3/31/20, and 6/30/20.